Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND1 Mutations

Clinical trial NCT05820152 · TERMINATED

Trial details

NCT number: NCT05820152
Sponsor: Neurophth Therapeutics Inc
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Leber Hereditary Optic Neuropathy (LHON)

Start date: 2023-08-15
Primary completion: 2024-06-24
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.